Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 621-623, April 2007

Quality of life impairment in hidradenitis suppurativa: A study of 61 cases

  • Pierre Wolkenstein, MD, PhD

      Affiliations

    • From the Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil
    • Corresponding Author InformationReprint requests: Pierre Wolkenstein, MD, PhD, Department of Dermatology, Hôpital Henri-Mondor, F-94010 Créteil Cedex, France.
    • ,
  • Anderson Loundou, PhD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Karine Barrau, MD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Pascal Auquier, MD, PhD

      Affiliations

    • Self-Perceived Health Assessment Research Unit, Public Health Department, School of Medicine, Marseille
    • ,
  • Jean Revuz, MD

      Affiliations

    • From the Department of Dermatology, Hôpital Henri-Mondor, AP-HP, Paris XII University, Créteil
    • ,
  • for the Quality of Life Group of the French Society of Dermatology

Accepted 20 August 2006. published online 27 October 2006.

Créteil and Marseille, France

Objective

We sought to determine quality of life impairment in hidradenitis suppurativa.

Methods

Questionnaires were administered to 61 patients.

Results

Quality of life impact in hidradenitis was much greater than that of several other dermatologic conditions.

Limitation

This hospital-based population may not be representative.

Conclusion

Hidradenitis is one of the most distressing conditions observed in dermatology.

Abbreviations used: ANOVA, analysis of variance, HS, hidradenitis suppurativa, NF1, neurofibromatosis 1, QoL, quality of life, SF-36, Short Form 36

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by PHRC 2005 (Hospital Clinical Research Program).Conflicts of interest: None identified.

PII: S0190-9622(06)02359-0

doi:10.1016/j.jaad.2006.08.061

Journal of the American Academy of Dermatology
Volume 56, Issue 4 , Pages 621-623, April 2007

Article Tools